Earth Science Tech, Inc. Launches DocProtocol.com

Miami, FL, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a holding entity currently focused on the health and wellness industry, today announces the launch of DocProtocol.com (“DocProtocol'').

As mentioned in the July 28, 2023, announced record fiscal Q1 2023 financial results, the Company created DocProtocol in May 2023. DocProtocol is operated by ETST’s subsidiary Peaks Curative (“Peaks”), and offers patient specific protocols to doctors and wellness centers for their patients. The protocols are developed by highly respected functional medicine professionals, and the company anticipates this asset will generate sales for two of its subsidiaries; Peaks Curative and RxCompoundStore..

DocProtocol makes it easy for Doctors, Healthcare Professionals, and Health & Wellness clinics to enter patient specific data (Age, Sex, Blood Panel, Etc.) and receive a protocol to treat the goals of the specific patient. The initial set of protocol offerings include: Weight Loss, Testosterone Therapy, Active Virus Therapy, Immune Booster Therapy, Long Acting Virus Therapy, Erectile Dysfunction, PMS Therapy, Body Sculpting and more. Over time, these protocols will be updated to adhere to changes in the medical landscape and new protocols will be added to address patient goals. Most of the protocols generated by DocProtocol require patient specific medications that can only be fulfilled by a compounding pharmacy.

Peaks Curative plans to monetize this asset for the benefit of ETST by charging a monthly fee to medical professionals for the use of DocProtocol as well as driving prescriptions to RxCompoundStore.

ETST’s CEO and Chairman of the Board, Giorgio R. Saumat comments, “Every asset we have acquired or launched in the last 10 months is geared towards growing the overall revenue and cash flow of the company. As each asset has come online, revenues have increased. To date, we have been successful with every asset launch. This is validation of the growth strategy management has implemented.

We expect DocProtocol to increase revenue and cash flow for ETST in two ways. Initially it will be indirect by offering a tool to providers that will require fulfillment by a compounding pharmacy of the patient’s choice. Then we expect providers to recognize the utility of DocProtocol and be willing to pay a monthly fee for its use.

This launch is consistent with our growth strategy and management’s commitment to executing that strategy.”

About Earth Science Tech, Inc.